Kidney transplantation

Area of Science:

• Nephrology
• Transplant Surgery
• Immunology

Background:

• End-stage renal disease (ESRD) presents a significant health challenge requiring effective treatment modalities.
• Dialysis is a common treatment for ESRD, but kidney transplantation offers a superior alternative for eligible patients.
• Historically, kidney transplantation has demonstrated safety and efficacy in managing irreversible ESRD.

Purpose of the Study:

• To evaluate kidney transplantation as a preferred treatment for end-stage renal disease (ESRD) in adults, infants, and children.
• To highlight the benefits of careful perioperative management in minimizing morbidity associated with kidney transplantation.
• To advocate for increased utilization of living donor grafts and advancements in immunosuppression for improved outcomes.

Main Methods:

• Review of treatment outcomes for end-stage renal disease (ESRD) comparing kidney transplantation and dialysis.
• Analysis of perioperative management strategies employed by surgical and anesthesiology teams.
• Assessment of the impact of immunosuppression advancements on graft and patient survival.

Main Results:

• Kidney transplantation is established as the preferred treatment for irreversible ESRD since 1990.
• Careful perioperative management by surgical and anesthesiology teams leads to very low morbidity rates.
• Increased utilization of living donor grafts is deemed warranted.
• Ongoing advancements in immunosuppression are expected to enhance long-term graft and patient survival.

Conclusions:

• Kidney transplantation is a safe and highly effective treatment for end-stage renal disease (ESRD) across all age groups.
• Optimized perioperative care and the use of living donor organs are crucial for successful transplantation.
• Continued progress in immunosuppressive therapies holds significant promise for improving long-term outcomes in kidney transplant recipients.